Skip to main content
. 2020 May 14;17(10):3425. doi: 10.3390/ijerph17103425

Table 1.

Participants’ characteristics at baseline and differences between groups.

Variable All Participants Tested at Baseline Completers 1-Year Post-Intervention
Total
(n = 44)
ME
(n = 23)
UC
(n = 21)
Total
(n = 44)
ME
(n = 23)
UC
(n = 21)
Anthropometric
Age (years) 51.2 (7.9) 50.4 (7.4) 52.0 (8.5) 50.7 (7.0) 48.8 (5.7) 52.8 (7.8)
Weight (kg) 62.9 (7.39) 61.6 (6.32) 64.3 (8.21) 62.9 (7.87) 61.3 (6.53) 64.7 (6.95)
Height (m) 1.6 (0.05) 1.6 (0.06) 1.6 (0.06) 1.6 (0.04) 1.6 (0.05) 1.6 (0.04)
BMI 24.57 (2.60) 24.17 (2.07) 24.98 (3.02) 24.55 (2.48) 23.89 (2.01) 25.27 (2.77)
Marital Status
Married 37/44 19 (82.6%) 18 (85.7%) 39/44 20 (87.0%) 19 (90.5%)
Single 7/44 4 (17.4%) 3 (14.3 %) 5/44 3 (13.0%) 2 (9.5%)
Blood Pressure
SBP at rest (mmHg) 121.3 (20.6) 117.7 (15.8) 125.0 (24.3) 121.6 (17.2) 118.3 (13.9) 125.3 (19.9)
DBP at rest (mmHg) 75.4 (10.6) 77.0 (11.0) 73.9 (10.2) 76.1 (10.0) 77.0 (11.2) 75.2 (8.6)
Mean Blood Pressure 90.7 (12.6) 90.5 (11.6) 90.9 (13.7) 91.3 (10.8) 90.7 (11.0) 91.9 (10.9)
Stage of illness
I 18/60 8 (26.7%) 10 (33.3%) 16/44 6 (26.1%) 10 (47.6%)
33/60 19 (63.3%) 14 (46.7%) 23/44 15 (65.2%) 8 (38.1%)
9/60 3 (10.0%) 6 (20.0%) 5/44 2 (8.7%) 3 (14.3%)
PT
Observation 7/44 3 (13.0%) 4 (19.0%) 5/44 2 (8.7%) 3 (14.3%)
Chemotherapy 15/44 7 (30.4%) 8 (38.1%) 18/44 9 (39.1%) 9 (42.9%)
Radiation therapy 1/44 1 (4.3%) 0(0%) 0/44 0 (0%) 0 (0%)
Radio-chemotherapy 21/44 12 (52.2%) 9 (42.9%) 20/44 12 (52.2%) 8 (38.1%)

SD, standard deviation; ME, multicomponent exercise group; UC, usual care group; BMI, Body Mass Index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PT, Phase of Treatment; KG, Kilogram. Values are n, mean (SD), or as otherwise indicated. Statistical evaluations were made by Analysis of Variance.